IPSC Stock Analysis: Buy, Sell, or Hold?
IPSC - Century Therapeutics, Inc. Common Stock
$2.18
-0.03 (-1.14%)
▼
5d:
-11.04%
30d:
+7.14%
90d:
-7.84%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 21, 2026
21d
Get Alerted When IPSC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IPSC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IPSC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IPSC is currently trading at $2.17, which is considered fair relative to its 30-day fair value range of $2.14 to $2.44.
Technical Outlook: Technically, IPSC is in a strong uptrend. The price is currently testing key support at $2.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IPSC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.67 (+66.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IPSC is in a strong uptrend. The price is currently testing key support at $2.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IPSC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.67 (+66.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.14 -
$2.44
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 66.7% below Wall St target ($3.67)
- CAUTION: 5-day price weakness (-11.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.14 -
$2.44
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.15
Resistance Level
$2.63
Current Trend
Strong Uptrend
Technical data as of
Apr 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.15
Wall Street Target
$3.67
(+66.7%)
Revenue Growth (YoY)
-100.0%
Profit Margin
-8.8%
Share & Embed Analysis
Last updated: April 29, 2026 12:48 PM ET
Data refreshes hourly during market hours. Next update: 1:48 PM
Data refreshes hourly during market hours. Next update: 1:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IPSC showing a specific setup today?
Insider Activity (6 Months)
3
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Gregory Russotti
SELL
10076 shares
2026-03-12
Douglas Carr
SELL
7043 shares
2026-03-12
Gregory Russotti
SELL
479 shares
2026-03-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 52 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 60 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 67 BUY |
